Biomunex Pharmaceuticals
PrivateLast Round
VC Round
Sep 30, 2025
Total Funding Raised
$3.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Biomunex Pharmaceuticals is a biopharmaceutical company that specializes in the discovery and development of innovative immuno-therapeutics, including bi- and multi-specific antibodies for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biomunex Pharmaceuticals Comparables
Compare Biomunex Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sino Biopharmaceutical | 78% | |
| Merus N.V. | 76% | |
| TRIO Pharmaceuticals, Inc. | 76% | |
Biomunex Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 30, 2025 | ||||
| Grant | Nov 3, 2021 | ||||
| Series A | Feb 16, 2021 |
Biomunex Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agence Nationale de la Recherche | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 83% MoM.
- May 8, 2026
Grew 20% QoQ, from 15 to 18 employees.
Biomunex Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biomunex Pharmaceuticals's valuation, stock price, and market status.